Hangzhou Biotest Biotech Co.,Ltd. (SHA:688767)
44.85
+0.41 (0.92%)
May 30, 2025, 2:45 PM CST
Revenue by Product
Fiscal year is January - December.
Fiscal Year | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | 2018 |
---|---|---|---|---|---|---|
Period Ending | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 | 2018 |
Point-of-care Testing Diagnostic Reagents | 435.93M |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Point-of-care Testing Diagnostic Reagents Growth | -76.98% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Original Design Manufacturer | - |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Original Brand Manufacturer | - |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Other Business | - |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Other Business Growth | - |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Infectious Disease Detection Series | - |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Infectious Disease Detection Series Growth | - |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Drug Abuse (Drugs) Testing Series | - |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Drug Abuse (Drugs) Testing Series Growth | - |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Reproductive Health Testing Series | - |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Reproductive Health Testing Series Growth | - |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Myocardial Marker Detection Series | - |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Myocardial Marker Detection Series Growth | - |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Tumor Marker Detection Series | - |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Tumor Marker Detection Series Growth | - |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Other Series | - |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Other Series Growth | - |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Revenue by Geography
Fiscal year is January - December.
Fiscal Year | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | 2018 |
---|---|---|---|---|---|---|
Period Ending | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 | 2018 |
Overseas | 308.16M |
Log In |
Log In |
Log In |
Log In | Upgrade
|
China | 127.77M |
Log In |
Log In |
Log In |
Log In | Upgrade
|
China Growth | -64.20% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
North America | - |
Log In |
Log In |
Log In |
Log In | Upgrade
|
North America Growth | - |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Europe | - |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Europe Growth | - |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Asia | - |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Asia Growth | - |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Other | - |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Other Growth | - |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Latin America | - |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Latin America Growth | - |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Africa | - |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Africa Growth | - |
Log In |
Log In |
Log In |
Log In | Upgrade
|